Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      Pneumococcal vaccine study for toddlers 12 to 15 months old

      We’re working closely with pediatricians and researchers to expand protection for toddlers against pneumococcal disease.

      Learn more

      20 trials found for Breast cancer, Breast Neoplasm

      All(20)
      Recruiting(18)
      Not yet recruiting(2)
      Recruiting
      NCT04767594
      First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.

      Breast Neoplasms

      Male or Female
      18+ years
      193study location(s)
      Recruiting
      NCT05253911
      Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.

      HER2-positive Breast Cancer

      Male or Female
      18+ years
      2study location(s)
      Recruiting
      NCT05748834
      Study of Tucatinib and Doxil in Participants with Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

      Breast Cancer

      Male or Female
      18+ years
      6study location(s)
      Recruiting
      NCT05208762
      A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

      Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma, Ovarian Neoplasms, Melanoma, Triple Negative Breast Neoplasms, Gastric Cancer

      Male or Female
      18+ years
      24study location(s)
      Recruiting
      NCT03445637
      Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®

      Breast Neoplasm

      Females
      18+ years
      1study location(s)
      Recruiting
      NCT04654208
      Swedish Ibrance Registries Insights (SIRI)

      Malignant Neoplasm of Breast

      Male or Female
      18 - 99 years
      1study location(s)
      Recruiting
      NCT04606446
      Study of PF-07248144 in Advanced or Metastatic Solid Tumors

      Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

      Male or Female
      18+ years
      106study location(s)
      Recruiting
      NCT04937660
      Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

      Metastatic Breast Cancer

      Male or Female
      18 - 90 years
      12study location(s)
      May 16, 2025 - Planned start date (Not yet recruiting)
      NCT04889495
      A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

      Non-small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Breast Cancer, Metastatic Kidney Cancer, Cervical Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

      Male or Female
      19+ years
      1study location(s)
      Dec 31, 2024 - Planned start date (Not yet recruiting)
      NCT04982848
      Korea Post Marketing Surveillance (PMS) Study of Talzenna®

      Breast Neoplasms

      Male or Female
      19+ years
      1study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(20)
      Recruiting(18)
      Not yet recruiting(2)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.